Yaz Kit
Product Images NDC 50419-405

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Yaz (NDC 50419-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formulas (0ed216ab 0c5e 4e77 8170 114a2c530ae7 03)

Structural Formulas (0ed216ab 0c5e 4e77 8170 114a2c530ae7 03)
This text consists of two drug names: Drospirenone and Ethinyl estradiol. These drugs are usually combined in birth control pills to prevent pregnancy. Drospirenone is a progestin and ethinyl estradiol is an estrogen. Together, they work by stopping ovulation and changing the cervical mucus to make it harder for sperm to reach the uterus. It does not protect against sexually transmitted infections.*
FDA Label Image

Blister (0ed216ab 0c5e 4e77 8170 114a2c530ae7 04)

FDA Label Image

Likelihood Of Developing A Serious Blood Clot (0ed216ab 0c5e 4e77 8170 114a2c530ae7 05)

Likelihood Of Developing A Serious Blood Clot (0ed216ab 0c5e 4e77 8170 114a2c530ae7 05)
This text appears to be a chart displaying the range of blood clot incidences in non-pregnant women, non-COC users, COC users, pregnant women, and postpartum women. The bottom section shows the number of women with a blood clot out of 10,000 women years (WY). The asterisk notes that the pregnancy data is based on actual duration of pregnancy in the reference studies, and the assumed rate is 7-27 per 10,000 WY.*
FDA Label Image

Carton (0ed216ab 0c5e 4e77 8170 114a2c530ae7 06)

FDA Label Image

50419 0405 01 Splimage30 Be195f3a

FDA Label Image

50419 0405 01 Splimage30 C11960eb

FDA Label Image

Fig 1 (Image 01)

FDA Label Image

Chart (Image 02)

Chart (Image 02)
This text provides information regarding different methods of birth control and the effectiveness rate of each method in terms of the number of pregnancies per 100 women in one year. The methods discussed include implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, and natural family planning methods such as no sex during the most fertile days of the monthly cycle, spermicide, and withdrawal. The text also indicates that there is an effectiveness gradient, with fewer than 1 pregnancy per 100 women being the most effective and 85 or more pregnancies per 100 women being the least effective.*
FDA Label Image

Image 03

Image 03
This text appears to describe the ranges of blood clot occurrences in non-pregnant women, non-coc users, coc users, pregnant women, and postpartum women. It also includes a table showing the number of women with a blood clot per 10,000 women years. The pregnancy data is based on actual duration of pregnancy in reference studies.*
FDA Label Image

Image 04

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.